Cargando…
Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells
The incretin receptors, glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR), are prime therapeutic targets for the treatment of type 2 diabetes (T2D) and obesity. They are expressed in pancreatic beta cells where they potentiate insulin release...
Autores principales: | Manchanda, Yusman, Bitsi, Stavroula, Chen, Shiqian, Broichhagen, Johannes, Bernardino de la Serna, Jorge, Jones, Ben, Tomas, Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016038/ https://www.ncbi.nlm.nih.gov/pubmed/36774542 http://dx.doi.org/10.1210/endocr/bqad028 |
Ejemplares similares
-
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
por: Fang, Zijian, et al.
Publicado: (2020) -
Reagents and models for detecting endogenous GLP1R and GIPR
por: Ast, Julia, et al.
Publicado: (2021) -
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
por: Killion, Elizabeth A., et al.
Publicado: (2020) -
Divergent acute versus prolonged pharmacological GLP-1R responses in adult β cell–specific β-arrestin 2 knockout mice
por: Bitsi, Stavroula, et al.
Publicado: (2023) -
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells
por: Buenaventura, Teresa, et al.
Publicado: (2019)